|
Jul 26
|
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
|
|
Jul 24
|
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
|
Jul 23
|
David Rubenstein Joins Moderna's Board of Directors
|
|
Jun 27
|
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
|
|
Jun 27
|
RSV vaccine makers’ shares fall as CDC adjusts shot guidance
|
|
Jun 27
|
2 Stocks Down More Than 30% to Buy Right Now
|
|
Jun 26
|
How consumer spending, election impact markets: Market Domination
|
|
Jun 26
|
Moderna, Pfizer, and GSK Stocks Fall After Vote on RSV Shots
|
|
Jun 26
|
Moderna Dives 11% After RSV Vaccine Proves Less Effective Than Pfizer, GSK Shots
|
|
Jun 26
|
US Equities Markets Close Higher Wednesday as Markets Review New Home Sales Data
|
|
Jun 26
|
Moderna stock dips on 50% RSV vaccine efficacy after 18 months
|
|
Jun 26
|
Lilly joins fellow pharma giants in OpenAI partnership
|
|
Jun 26
|
Moderna RSV Vaccine Efficacy Sinks Over Time, CDC Documents Show
|
|
Jun 26
|
Sector Update: Health Care Stocks Lower in Afternoon Trading
|
|
Jun 26
|
Why Is Moderna Stock Trading Lower On Wednesday?
|
|
Jun 26
|
Moderna shares decline, RSV vaccine efficacy lags behind competitors
|
|
Jun 25
|
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
|
|
Jun 25
|
Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
|
|
Jun 24
|
The FDA awarded a record number of review designations to mRNA vaccines in 2023
|
|
Jun 18
|
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
|